Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor

References

• Aggarwal A, Esler MD, Lambert GW, Hastings J, Johnston L, Kaye DM. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Circulation 2002; 105: 1031–1033
   PubMed Web of Science ®Google Scholar
• Alvarenga ME, Richards JC, Lambert G, Esler MD. Psychophysiological mechanisms in panic disorder: A correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med 2006; 68: 8–16
   PubMed Web of Science ®Google Scholar
• American Psychological Association. Diagnostic and statistical manual of mental disorders, fourth edition. American Psychiatric Association, Washington DC 1994
   Google Scholar
• Bagdy G. Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences. Ann NY Acad Sci 1998; 851: 357–363
   Google Scholar
• Brown TA, DiNardo PA, Barlow DH. Anxiety disorders interview schedule for DSM-IV (ADIS-IV). Graywind Publications, San Antonio 1994
   Google Scholar
• Burghardt NS, Sullivan GM, McEwen BS, Gorman JN, Le Doux JE. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: A comparison with tianeptine. Biol Psychiatry 2004; 55: 1171–1178
   PubMed Web of Science ®Google Scholar
• Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984; 247: E21–E28
   PubMed Web of Science ®Google Scholar
• Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, Kelly M, Esler MD. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 1993; 11: 1217–1227
   PubMed Web of Science ®Google Scholar
• Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown obsessive compulsive scale I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006–1011
   PubMed Web of Science ®Google Scholar
• Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996; 54: 129–141
   PubMed Web of Science ®Google Scholar
• Graeff FG, Viana MB, Mora PO. Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 1997; 21: 791–799
   PubMedGoogle Scholar
• Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83–87
   PubMed Web of Science ®Google Scholar
• Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621–2624
   PubMed Web of Science ®Google Scholar
• Kennaway DJ, Moyer RW. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms. Brain Res 1998; 806: 257–270
   PubMed Web of Science ®Google Scholar
• Kirby LG, Allen AR, Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 1995; 682: 189–196
   PubMed Web of Science ®Google Scholar
• Lambert GW, Eisenhofer G, Cox HS, Horne M, Kalff V, Kelly M, Jennings GL, Esler MD. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. Life Sci 1991; 49: 1061–1072
   PubMed Web of Science ®Google Scholar
• Lambert GW, Kaye DM, Cox HS, Vaz M, Turner AG, Jennings GL, Esler MD. Regional 5-hydroxyindoleacetic acid production in humans. Life Sci 1995a; 57: 255–267
   PubMed Web of Science ®Google Scholar
• Lambert GW, Kaye DM, Vaz M, Cox HS, Turner AG, Jennings GL, Esler MD. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: Effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. J Auton Nerv Syst 1995b; 55: 169–178
   PubMedGoogle Scholar
• Lambert GW, Kaye DM, Thompson JM, Turner AG, Cox HS, Vaz M, Jennings GL, Wallin BG, Esler MD. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta Physiol Scand 1998; 163: 155–163
   Google Scholar
• Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002; 360: 1840–1842
   PubMed Web of Science ®Google Scholar
• Lambert GW, Vaz M, Cox HS, Turner AG, Kaye DM, Jennings GL, Esler MD. Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. Clin Sci (Lond) 1999; 96: 191–197
   Google Scholar
• Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531
   PubMed Web of Science ®Google Scholar
• Maas JW, Hattox SE, Greene NM, Landis DH. 3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo. Science 1979a; 205: 1025–1027
   PubMed Web of Science ®Google Scholar
• Maas JW, Hattox SE, Martin DM, Landis DH. A direct method for determining dopamine synthesis and output of dopamine metabolites from brain in awake animals. J Neurochem 1979b; 32: 839–843
   PubMed Web of Science ®Google Scholar
• Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A, Vasar V, Shlik J. Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol 2005; 8: 261–266
   PubMed Web of Science ®Google Scholar
• Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991; 325: 618–624
   PubMed Web of Science ®Google Scholar
• Nash JR, Sargen PA, Rabiner EA, Hood SD, Argyropoulos SV, Grasby RM, Nutt DI. Altered 5HT1A binding in panic disorder demonstrated by positron emission tomography. Eur Neuropsychopharm 2004; 14: S322–S323
   Google Scholar
• Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets WC. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 2004; 24: 589–591
   PubMed Web of Science ®Google Scholar
• Norman TR. The new antidepressants—mechanisms of action. Aust Prescrib 1999; 22: 106–108
   Google Scholar
• Olivier B, Pattij T, Wood SJ, Oosting R, Sarnyai Z, Toth M. The 5-HT(1A) receptor knockout mouse and anxiety. Behav Pharmacol 2001; 12: 439–450
   PubMed Web of Science ®Google Scholar
• Redmond DE, Jr, Huang YH. Current concepts. II. New evidence for a locus coeruleus–norepinephrine connection with anxiety. Life Sci 1979; 25: 2149–2162
   PubMed Web of Science ®Google Scholar
• Rueter LE, Jacobs BL. A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations. Brain Res 1996; 739: 57–69
   Google Scholar
• Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997; 154: 1571–1575
   PubMed Web of Science ®Google Scholar
• Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J, Houck P, Wang T. Reliability and validity of the panic disorder severity scale: Replication and extension. J Psychiatr Res 2001; 35: 293–296
   PubMed Web of Science ®Google Scholar
• Shimizu N, Take S, Hori T, Oomura Y. In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: Significant enhancement by immobilization stress in rats. Brain Res Bull 1992; 28: 727–734
   Google Scholar
• Singewald N, Kaehler S, Hemeida R, Philippu A. Release of serotonin in the rat locus coeruleus: Effects of cardiovascular, stressful and noxious stimuli. Eur J Neurosci 1997; 9: 556–562
   PubMed Web of Science ®Google Scholar
• Sullivan GM, Oquendo MA, Huang YY, Mann JJ. Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. Int J Neuropsychopharmacol 2006; 9: 547–556
   PubMed Web of Science ®Google Scholar
• Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995; 374: 542–546
   PubMed Web of Science ®Google Scholar
• Tork I. Anatomy of the serotonergic system. Ann NY Acad Sci 1990; 600: 9–34
   PubMed Web of Science ®Google Scholar
• Wilkinson DJ, Thompson JM, Lambert GW, Jennings GL, Schwarz RG, Jefferys D, Turner AG, Esler MD. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry 1998; 55: 511–520
   PubMed Web of Science ®Google Scholar
• Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999; 21(Suppl 2)52S–60S
   Google Scholar
• Ziegler DR, Cass WA, Herman JP. Excitatory influence of the locus coeruleus in hypothalamic–pituitary–adrenocortical axis responses to stress. J Neuroendocrinol 1999; 11: 361–369
   PubMed Web of Science ®Google Scholar